Document is current
Any future updates will be listed below
-
Authors
Catanzaro, Elena https://orcid.org/0000-0001-7699-3414
Beltrán-Visiedo, Manuel
Galluzzi, Lorenzo https://orcid.org/0000-0003-2257-8500
Krysko, Dmitri V. https://orcid.org/0000-0002-9692-2047
- License Information
-
More Information
Article History
Received: 17 October 2024
Accepted: 18 November 2024
First Online: 10 December 2024
Competing interests
: LG holds research contracts with Lytix Biopharma, Promontory and Onxeo; Has received consulting/advisory honoraria from Boehringer Ingelheim, AstraZeneca, AbbVie, OmniSEQ, Onxeo, The Longevity Labs, Inzen, Imvax, Sotio, Promontory, Noxopharm, EduCom, and the Luke Heller TECPR2 Foundation; and holds Promontory stock options. The other authors have no conflicts of interest to declare.
